Navigation Links
BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Date:8/19/2007

Significant Improvement in Number and Viability of Stem Cells Derived from

Cord Blood Enabled by BioLife's Patented Preservation Media

BOTHELL, Wash., Aug. 17 /PRNewswire-FirstCall/ -- BioLife Solutions Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced an agreement as the exclusive supplier of preservation media to the New England Cryogenic Center, Inc. (NECC), one of the world's largest providers of cryogenically preserved human cells and tissues.

The five year agreement includes volume based pricing and an exclusive commitment from NECC to purchase all of its demand for cord blood preservation media from BioLife.

New England Cord Blood Bank Chief Executive John Rizza remarked: "We continually strive to improve our cord blood preservation protocols and results, and we've seen significant improvement in post-thaw cell recovery and viability with BioLife's CryoStor, compared to our prior in-house media formulations. In addition, pre-formulated and sterile CryoStor eliminates our labor cost of mixing preservation media in our lab. CryoStor is also serum-free and protein-free, so this resolved an albumin supply issue we faced. Based on our early experience, we're quite interested in evaluating BioLife's preservation media for use by our affiliated sperm bank and for other emerging stem cell applications."

BioLife Chief Executive Mike Rice commented: "The New England Cryogenic Center and their affiliates around the world are on the leading edge of preservation science, so we're very pleased to become their exclusive supplier and count them as a key customer and research partner in developing new applications for CryoStor and other our preservation media products."

According to an August 2006 research report published by Jain PharmaBiotech, the total value of cell-based markets was $27 billion
'/>"/>

SOURCE BioLife Solutions Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sample Preparation Solutions for Cellular Protein Fractionation Poster, Rev A
2. Long-Term Instrument Control and Connectivity Solutions
3. PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26)
4. Verifying Multichannel Pipettor Performance with Standard Dispense Solutions in the SpectraMax Plus (MaxLine Application Note #28)
5. Software company enters health space with RFID solutions on hold
6. eCare Solutions, UW Milwaukee to study health web sites
7. Tech Digest - RedPrairie; Wind Lake Solutions
8. Cooper Lighting picks RedPrairie solutions
9. Ten resolutions that could produce a happy new (tech) year
10. Inacom named Microsofts favorite learning solutions partner of the year
11. Blue Cross BlueShield of South Carolina implements Esker solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...all/ - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) today...ructuring plans to further reduce its cash burn ra...exploring strategic alternatives that may,include ... with this,process, the Company has also completed...d has determined that it is in the best interest o...
(Date:7/3/2008)...y, July 3,/- Rosetta Genomi...croRNA-based diagnostics and therapeutics, announc...nual Growth Conference on,Wednesday, July 9, at 8:...rk., About Rosetta Genomics, Rosetta Genomics (N...A.,Founded in 2000, the company,s integrative rese...
(Date:7/2/2008)...briva Therapeutics, a,specialist in antibiotics de...s been appointed as Chief Executive Officer of the...ly twenty years of industry,experience serving mos...nt,Licensing & Strategy for the oncology business...ible for the full array of business development,ac...
(Date:7/2/2008)...nstrate Superiority Over,Market-Leading Stent in C... Treatment of Coronary Artery Dis...Call/ -- Abbott today,announced that the U.S. Food...(TM) V Everolimus Eluting Coronary Stent System fo... V is the only drug eluting stent to have,demonstr...
Breaking Biology Technology:Vasogen Provides Corporate Update 2Nabriva Therapeutics Announces Appointment of New CEO 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5
...e years ago, it wasnt necessary to use terms such ...er when talking about the state economy. That was ...d other global trends fundamentally changed the Wi...at had relied for decades on the strength of its b..., innovative and often tech-savvy small companies ...
...oday, a properly structured and truly protected gl...ason, a single name fully guarded for its iconic p...uipped with a matching dot-com is the most sought-...orth a hundred times more than the head office bui...the stacking chimneys combined. Just ask Sony, Rol...
...rtford, Wis. Emergency vehicle drivers have a ne... with Hydro Electronic Devices dashboard video s... and lights with a display screen no larger than s...ols while providing drivers with more information.... Schmitz of the Schmitz Company , public relation...
...dison, Wis. Governor Jim Doyle announced Wiscons...day with the creation of the Biofuels Initiative. ...l sources, such as ethanol from corn, and research...in, we may not have oil fields, but we have the co... wind and sun and biofuels. And we have ingenuity....
Other Biology Technology:Wisconsin Angel Network is part of states focus on entrepreneurship 2Wisconsin Angel Network is part of states focus on entrepreneurship 3Global branding is easy with global trademarks 2Global branding is easy with global trademarks 3Global branding is easy with global trademarks 4Hartford firm brings video to the dashboard 2Hartford firm brings video to the dashboard 3Governor wants $2 million for biofuels in budget 2
(Date:7/3/2008)...,, The problem with antibiotics is that, event.... But by targeting the gene that confers such resi...hem. Rockefeller University scientists tested the ... deadliest strains of multidrug-resistant Staphylo...le for the great majority of staphylococcal infect...
(Date:7/2/2008)..., Arlington, Virginia (July 2, 2008) Led by a bo... industrial powers have the opportunity at the upc...stantive action against climate change. , German...illion Euros over four years to conserve tropical ...forest protection, starts to address a major sourc...
(Date:7/2/2008)..., , TALLAHASSEE, Fla. -- A Florida State Univer...ues to evaluate a new class of cancer-killing drug...earchers. , Kevin C. Chen, an assistant professo...orida A&M University-Florida State University Coll...s to determine how substances known as recombinant...
(Date:7/2/2008)..., WALNUT CREEK, CAIn the continuing effort to tap...bial and plant domains for bioenergy and environme...(DOE JGI) has announced its latest portfolio of DN...e coming year. The 44 projects, culled from nearly...encing Program (CSP), represent over 60 billion nu...
Breaking Biology News(10 mins):New antibiotic beats superbugs at their own game 2G8 summit: Opportunity for immediate action on climate change 2G8 summit: Opportunity for immediate action on climate change 3FSU researcher using computers to hone cancer-fighting strategies 2US Department of Energy Joint Genome Institute announces new genome sequencing projects 2US Department of Energy Joint Genome Institute announces new genome sequencing projects 3US Department of Energy Joint Genome Institute announces new genome sequencing projects 4US Department of Energy Joint Genome Institute announces new genome sequencing projects 5US Department of Energy Joint Genome Institute announces new genome sequencing projects 6US Department of Energy Joint Genome Institute announces new genome sequencing projects 7Many African Americans have a gene that prolongs life after heart failure 2966 1Many African Americans have a gene that prolongs life after heart failure 2966 2Many African Americans have a gene that prolongs life after heart failure 2966 3Many African Americans have a gene that prolongs life after heart failure 2966 4Filling in the Alzheimers Race Gap 17254 2/ 1Filling in the Alzheimers Race Gap 17254 2/ 2PCMA Response to New York Times Article on Biotech Medicine Costs 17250 1PCMA Response to New York Times Article on Biotech Medicine Costs 17250 2Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 1855 1Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 1855 2Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 1855 3
...[the current system] is that the public misunderst... the time of marketing, while [adverse] events occ...undetected." , In the May 3 issue of the Journal o..., MD, MPH, Professor of Public Health and Preventi...istics and Epidemiology at the University of Penns...
...ed technology for the isolation and enrichment of ... therapies to repair or replace diseased or damage...nt and faster than traditional technology used for...today at the International Society for Cellular Th...he Pall Corporation (NYSE: PLL) Filter Harvest Sys...
...ed technology for the isolation and enrichment of ... therapies to repair or replace diseased or damage...nt and faster than traditional technology used for...today at the International Society for Cellular Th...he Pall Corporation (NYSE: PLL) Filter Harvest Sys...
...adian Medical Association Journal shows that young... as likely as the total population of young Canadi...lleagues collected and analyzed Canadian data on f...termine rates, identify patterns and devise preven...hat children 1? years old, particularly boys, when...
Other Biology News:How the US drug safety system should be changed 2Embryos exposed in 3-D 2New technology enables faster, more efficient cell harvest: Cell therapy meeting study 2
Used in May-Grunwald Giemsa stain.
Normal Bovine Serum; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin lev
Bromphenol Blue, ACS Reagent from Research Organics, Inc.
GeneTailor Site-Directed Mutagenesis System from Invitrogen
Biology Products: